| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e071d18fea054bf8d1420d483e78ed1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8381805eba6d034fc77bd230dd02e6e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4319fe3d827bd24add491d4ed90e7692 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6925
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2009-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6379296af7e3c25e737ca118f38e863a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_820aed6e72b0fc928d42edac4f76e5b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aaad0bbb45f4de3c30eae8b763a84431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3bc180c390cb967be0643980b2d6e8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c15e8feb536e45fa0c26e8a2acdf3dec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74ddf7bef1c239c0b090f200c512a1a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_192324a000b1c634264d1d70e4d7dd15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e18fa4ad456059a7b0555896bbc3ad4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3eaa9f06098d4b5f95f1e758889b9c7 |
| publicationDate |
2013-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2009303344-B8 |
| titleOfInvention |
Targeting of antigen presenting cells with immunonanotherapeutics |
| abstract |
The present invention provides compositions and systems for delivery of nanocarriers to cells of the immune system. The invention provides nanocarriers capable of stimulating an immuse response in T cells and/or in B cells. The invention provides nanocarriers that comprise an immunofeature surface. The nanocarriers are capable of targeting antigen presenting cells when administered to a subject. The invention provides pharmaceutical compositions comprising nanocarriers. The present invention provides methods of designing, manufacturing, and using nanocarriers and pharmaceutical compositions thereof. |
| priorityDate |
2008-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |